<DOC>
	<DOCNO>NCT01859585</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Parecoxib Ketorolac preemptive analgesia patient undergo lumbar spinal fusion .</brief_summary>
	<brief_title>Efficacy Parecoxib Ketorolac Preemptive Analgesia Spine Fusion</brief_title>
	<detailed_description>A prospective , double-blinded randomize control trial . Randomly allocate patient undergo posterior lumbar spinal fusion 3 group ( n=32 ) receive Parecoxib , Ketorolac Placebo around 30 minute prior incised skin . Efficacy assess visual analog scale score ( 0-10 ) , total opioid consumption , complication bleeding also record .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Patients undergo lumbar spinal fusion one three level ASA class I II History allergy Sulfa group History allergy OPOID NSAIDs Contraindicate NSAIDs use History coagulopathy platelet disfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>preemptive analgesia</keyword>
	<keyword>lumbar fusion</keyword>
	<keyword>Parecoxib</keyword>
	<keyword>Ketorolac</keyword>
</DOC>